Ocugen OCGN
NASDAQ OCGN
$0.96 +0.01 (+1.09%)
At close: Nov 11, 2026 · 4:00 PM EST

Ocugen (OCGN) Non-Current Deferred Revenue (2018 - 2019)

Updated

Ocugen's Non-Current Deffered Revenue was $10 million in Q2 2019, up 300.0% from $2.5 million a year earlier and unchanged from the prior quarter.

Analysis

Ocugen (OCGN) Non-Current Deferred Revenue (2018 - 2019) Analysis & Trends

From Q1 2018 onward, Ocugen has reported Non-Current Deffered Revenue for 6 quarters.

  • Per Business Quant data, OCGN's Non-Current Deffered Revenue in the three quarters before Q2 2019 was $10 million (Q1 2019), $10 million (Q4 2018) and $5 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Ocugen 322.34 Mn 87.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 10.00 Mn
Mar 31, 2019 10.00 Mn
Dec 31, 2018 10.00 Mn
Sep 30, 2018 5.00 Mn
Jun 30, 2018 2.50 Mn
Mar 31, 2018 5.00 Mn
API Access

Ocugen Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=OCGN&period=max&api_key=YOUR_API_KEY